Merriman Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $622K | Buy |
3,499
+208
| +6% | +$37K | 0.03% | 120 |
|
|
2024
Q3 | $650K | Buy |
3,291
+4
| +0.1% | +$790 | 0.03% | 127 |
|
|
2024
Q2 | $564K | Sell |
3,287
-24
| -0.7% | -$4.12K | 0.02% | 133 |
|
|
2024
Q1 | $603K | Buy |
3,311
+4
| +0.1% | +$728 | 0.03% | 124 |
|
|
2023
Q4 | $513K | Buy |
3,307
+100
| +3% | +$15.5K | 0.02% | 129 |
|
|
2023
Q3 | $478K | Hold |
3,207
| – | – | 0.02% | 122 |
|
|
2023
Q2 | $432K | Sell |
3,207
-48
| -1% | -$6.47K | 0.02% | 145 |
|
|
2023
Q1 | $519K | Hold |
3,255
| – | – | 0.03% | 125 |
|
|
2022
Q4 | $526K | Buy |
3,255
+113
| +4% | +$18.3K | 0.03% | 138 |
|
|
2022
Q3 | $422K | Buy |
3,142
+41
| +1% | +$5.51K | 0.03% | 108 |
|
|
2022
Q2 | $475K | Sell |
3,101
-31
| -1% | -$4.75K | 0.03% | 103 |
|
|
2022
Q1 | $508K | Sell |
3,132
-350
| -10% | -$56.8K | 0.04% | 127 |
|
|
2021
Q4 | $471K | Buy |
3,482
+469
| +16% | +$63.4K | 0.03% | 148 |
|
|
2021
Q3 | $325K | Sell |
3,013
-9
| -0.3% | -$971 | 0.03% | 162 |
|
|
2021
Q2 | $340K | Buy |
3,022
+145
| +5% | +$16.3K | 0.03% | 174 |
|
|
2021
Q1 | $311K | Sell |
2,877
-953
| -25% | -$103K | 0.04% | 154 |
|
|
2020
Q4 | $411K | Buy |
+3,830
| New | +$411K | 0.04% | 155 |
|
|
2020
Q3 | – | Sell |
-2,362
| Closed | -$232K | – | 161 |
|
|
2020
Q2 | $232K | Sell |
2,362
-371
| -14% | -$36.4K | 0.04% | 147 |
|
|
2020
Q1 | $208K | Sell |
2,733
-355
| -11% | -$27K | 0.05% | 142 |
|
|
2019
Q4 | $273K | Buy |
+3,088
| New | +$273K | 0.05% | 151 |
|